Improved survival for patients with testicular cancer in Europe since 1978

European Journal of Cancer

Volumn 34, Issue 14, 1998, Pages 2236-2240

  Aareleid, T ^a,f   Sant, M ^b   Hedelin G ^c   Oberaigner, W ^d   Storm, H ^e   Hakulinen, T ^g   Mace Lesec'h, J ^h   Arveux, P ⁱ   Esteve, J ^j   Raverdy, N ^k   Ziegler, H ^l   Tryggvadottir, L ^m   Tulinius, H ^m   Berrino, F ⁿ   Crosignani, P ^o   Gatta, G ^o   Micheli, A ^o   Conti, E ^p   Vercelli, M ^q   Federico, M ^r   Mangone, L ^r   De Lisi, V ^s   Zanetti, R ^t   Gafa, L ^u   Tumino, R ^u   Falcini, F ^v   Barchielli, A ^w   Capocaccia, R ^x   De Angelis, G ^x   Valente, F ^x   Verdecchia, A ^x   Pawlega, J ^y   Rachtan, J ^y   Bielska Lasota, M ^z   Wronkowski, Z ^z   Obsitnikova, A ^aa   Plesko, I ^aa   Pompe Kirn, V ^ab   Izarzugaza, I ^ac   Garau, I ^ad   Ardanaz, E ^ae   Moreno, C ^ae   Galceran, J ^af   Moller, T ^ag   Torhorst, J ^ah   Bouchardy, C ^ai   Raymond, L ^ai   Coebergh, J W W ^aj   Gould, A ^ak   Black, R J ^ak   Davies, T W ^al   Stockton, D ^al   Coleman, M P ^am   Williams, E M I ^an   Littler, J ^an   Forman, D ^ao   Quinn, M J ^ap   Roche, M ^aq   Smith, J ^ar   Bell, J ^as   Lawrence, G ^at   more..

^a Institute of Experimental and Clinical Medicine Tallinn   (Estonia)

^b Ist Naz Per Lo Stud Cura Dei T ^*  (Italy)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Tumor Registry Tirol   (Austria)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f Estonian Cancer Registry   (Estonia)

^g FINNISH CANCER REGISTRY   (Finland)

^h Calvados General Cancer Registry   (France)

ⁱ Doubs Cancer Registry   (France)

^j INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^k Somme Cancer Registry   (France)

^l SAARLAND CANCER REGISTRY   (Germany)

^m ICELANDIC CANCER REGISTRY   (Iceland)

ⁿ Project Leader   (Italy)

^o Lombardy Cancer Registry   (Italy)

^p Latina Cancer Registry   (Italy)

^q Liguria Cancer Registry   (Italy)

^r MODENA CANCER REGISTRY   (Italy)

^s PARMA CANCER REGISTRY   (Italy)

^t Center for Epidemiology and Prevention in Oncology   (Italy)

^u Ragusa Cancer Registry   (Italy)

^v Romagna Cancer Registry   (Italy)

^w Tuscan Cancer Registry   (Italy)

^x ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^y Cracow Cancer Registry   (Poland)

^z INSTITUTE OF ONCOLOGY   (Poland)

^aa National Cancer Registry of   (Slovakia)

^ab INSTITUTE OF ONCOLOGY   (Slovenia)

^ac Departamento de Sanidad Gobierno Vasco   (Spain)

^ad Mallorca Cancer Registry   (Spain)

^ae Navarra Cancer Registry   (Spain)

^af Tarragona Cancer Registry   (Spain)

^ag Southern Swedish Regional Tumour Registry   (Sweden)

^ah Cancer Registry of Basel   (Switzerland)

^ai GENEVA CANCER REGISTRY   (Switzerland)

^aj Eindhoven Cancer Registry ^*  (Netherlands)

^ak Scottish Cancer Registry   (United Kingdom)

^al East Anglian Cancer Registry   (United Kingdom)

^am LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^an Merseyside and Cheshire Cancer Registry   (United Kingdom)

^ao Northern and Yorkshire Cancer Registry and Information Service   (United Kingdom)

^ap OYce for National Statistics   (United Kingdom)

^aq UNIVERSITY OF OXFORD   (United Kingdom)

^ar S and West Cancer Intelligence Unit   (United Kingdom)

^as Thames Cancer Registry   (United Kingdom)

^at W Midlands Cancer Intelligence Unit   (United Kingdom)

more..

Author keywords

Europe; Intercountry comparisons; Population based cancer registries; Survival rates; Testicular cancer; Time trends

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; DATA ANALYSIS; ESTONIA; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TESTIS CANCER;

EID: 0032427004     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00313-X     Document Type: Article

References (21)

1. Black R.J., Bray F., Ferlay J., Parkin D.M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 33:1997;1075-1107.
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer in Five Continents, Volume VII. IARC Scientific Publications No. 143. Lyon, International Agency for Research on Cancer, 1997.
3. Coleman MP, Estève J, Damiecki P, Arslan A, Renard H, eds. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121. Lyon, International Agency for Research on Cancer, 1993.
4. Bergström R, Adami HO, Möhner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996, 88, 727-733.
5. Einhorn LH, Richie JP, Shipley WU. Cancer of the testis. In DeVita VT Jr, Hellmann S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Philadelphia, J.B. Lippincott Co, 1993, 1126-1151.
6. Einhorn L.H. Salvage therapy for germ cell tumors. Semin Oncol. 21:(Suppl. 7):1994;47-51.
7. van Basten J.P., Schraffordt Koops H., Sleijfer D. Th., Pras E., van Driel M.F., Hoekstra H.J. Current concepts about testicular cancer. Eur J Surg Oncol. 23:1997;354-366.
8. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publications No. 132. Lyon, International Agency for Research on Cancer, 1995.
9. Coebergh JWW. Summary and discussion of results. In Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publications No. 132. Lyon, International Agency for Research on Cancer, 1995, 447-463.
10. Hakulinen T., Abeywickrama K.H. A computer program package for relative survival analysis. Computer Progr Biomed. 19:1985;197-207.
11. Verdecchia A, Capocaccia R, Hakulinen T. Methods of data analysis. In Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publications No. 132. Lyon, International Agency for Research on Cancer, 1995, 32-37.
12. La Vecchia C., Negri E., Levi F., Decarli A., Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer. 34:1998;118-141.
13. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1994. NIH Pub. No. 97-2789. Bethesda, National Cancer Institute, 1997.
14. Bonett A, Dickman P, Roder, Gibberd R, Hakulinen T. Survival of Cancer Patients in South Australia 1977-1990. Scientific Publication No 2. South Australian Central Cancer Registry, 1992.
15. The Cancer Registry of Norway. Cancer in Norway 1995. The Cancer Registry of Norway, Institute of Epidemiological Cancer Research, Oslo, 1998.
16. Pukkala E, Rimpelä A, Läärä E. Syöpä Suomessa. Suomen Syöpärekisteri, 1991.
17. Møller H, Friis S, Krüger Kjær S. Survival of Danish Cancer Patients. Male genital organs. APMIS 1993, 101(Suppl. 33), 122-136.
18. Selby P., Gillis C., Haward R. Benefits from specialised cancer care. Lancet. 348:1996;313-318.
19. Boyle P., Maisonneuve P., Kaye S.B. Therapy for testicular cancer in Central and Eastern Europe. Lancet. 335:1990;1033.
20. Hernes E.H., Harstad K., Fosså D. Changing incidence and delay of testicular cancer in southern Norway (1981-1992). Eur Urol. 30:1996;349-357.
21. Adami H.O. What is progress against cancer? Cancer Causes Control. 4:1993;483-487.